# Study of AGN-190584 Eye Drops to Assess Safety and Efficacy in Participants Aged 40-80 Years With Pseudophakic Presbyopia

> **NCT05393089** · PHASE2 · WITHDRAWN · sponsor: **Allergan**

## Conditions studied

- Presbyopia

## Interventions

- **DRUG:** AGN-190584
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT05393089
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-06-09
- **Primary completion:** 2023-04-04
- **Final completion:** 2023-04-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Business Decision
- **Last updated:** 2022-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05393089

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05393089, "Study of AGN-190584 Eye Drops to Assess Safety and Efficacy in Participants Aged 40-80 Years With Pseudophakic Presbyopia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05393089. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*